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Gain-of-Function Mutations in PDR1, a Regulator of Antifungal Drug
Resistance in Candida glabrata, Control Adherence to Host Cells
Luís Vale-Silva,a Françoise Ischer,a Salomé Leibundgut-Landmann,b Dominique Sanglarda
Institute of Microbiology, University of Lausanne and University Hospital Center, Lausanne, Switzerlanda; Institute of Microbiology, Swiss Federal Institute of Technology,
Zürich, Switzerlandb
Candida glabrata is an emerging opportunistic pathogen that is known to develop resistance to azole drugs due to increased
drug efflux. The mechanism consists of CgPDR1-mediated upregulation of ATP-binding cassette transporters. A range of gain-
of-function (GOF) mutations in CgPDR1 have been found to lead not only to azole resistance but also to enhanced virulence.
This implicates CgPDR1 in the regulation of the interaction of C. glabratawith the host. To identify specific CgPDR1-regulated
steps of the host-pathogen interaction, we investigated in this work the interaction of selected CgPDR1GOFmutants with mu-
rine bone marrow-derived macrophages and human acute monocytic leukemia cell line (THP-1)-derived macrophages, as well as
different epithelial cell lines. GOFmutations in CgPDR1 did not influence survival and replication within macrophages follow-
ing phagocytosis but led to decreased adherence to and uptake by macrophages. This may allow evasion from the host’s innate
cellular immune response. The interaction with epithelial cells revealed an opposite trend, suggesting that GOFmutations in
CgPDR1may favor epithelial colonization of the host by C. glabrata through increased adherence to epithelial cell layers. These
data reveal that GOFmutations in CgPDR1modulate the interaction with host cells in ways that may contribute to increased
virulence.
Candida glabrata is a commensal yeast that has emerged as animportant opportunistic pathogen and has become the sec-
ondmost common cause of candidiasis afterCandida albicans (1).
Infections caused by C. glabrata have increased steadily in fre-
quency over the last few decades. Previously available epidemio-
logical data showed a proportion of bloodstream infections
caused by C. glabrata among all Candida spp. ranging from about
5% in Latin America to 25% inNorth America (1). The latest data
illustrate a continual rise, with C. glabrata now accounting for up
to 11.2%and29%of candidemia episodes inBrazil and theUnited
States, respectively, at the expense of C. albicans (2, 3). Addition-
ally, C. glabrata intrinsically displays reduced susceptibility to az-
ole drugs and shows a high propensity to develop secondary resis-
tance, typically due to increased drug efflux (4). This mechanism
is mediated by upregulation of a single or a combination of a few
ATP-binding cassette (ABC) transporters, among which are at
least CgCDR1, CgCDR2, and CgSNQ2 (5–9). Upregulation of
ABC transporters occurs following alterations in their major reg-
ulator, the zinc cluster transcription factor CgPDR1 (10, 11).
CgPDR1 combines functional attributes of transcription factors
PDR1 and PDR3 from the nonpathogenic baker’s yeast Saccharo-
myces cerevisiae (12).Wehave previously found that gain-of-func-
tion (GOF)mutations inCgPDR1 lead not only to azole resistance
in vitro and in vivo but also to gain of virulence in murine models
of disseminated infection (13). Further work has shown that two
CgPDR1-regulated proteins, the ABC transporter CgCdr1 and a
hitherto-uncharacterized mitochondrial protein, Pup1, partially
contribute to the gain of virulence (14).
C. glabrata is closely related to the nonpathogenic S. cerevisiae,
but it appears to have evolved important attributes allowing ad-
aptation to pathogenesis, namely, adherence to host cells, stress
resistance, ability to sustain starvation, and antifungal drug resis-
tance (15). Even though it lacks some well-established virulence
factors of C. albicans, like true hyphal formation or hydrolase se-
cretion, C. glabrata is able to access the bloodstream and dissem-
inate to internal organs in susceptible patients. These transloca-
tion mechanisms are, however, not yet well understood. A
remarkable characteristic of C. glabrata infections is that the or-
ganism is able to persist over long periods in immunocompetent
mice upon systemic challenge without causing disease or high
inflammation (16–19). This suggests an ability to subvert the
host’s first line of defense, which includes cells of the innate im-
mune system. Macrophages, in particular, are essential for both
innate and adaptive immunity. They play key roles in microbial
phagocytosis and killing, and they are involved in downstream
effects such as antigen processing and presentation or cytokine
production.
Being able to evade the control of cellular innate immunity
may thus be a major attribute of C. glabrata pathogenesis. Two
general strategies are employed by microbes to survive attacks by
the host’s cellular innate immunity: on one hand, prevention of
phagocytosis, and on the other hand, intracellular survival and
escape from phagocytes (20). The former strategy relies mainly on
concealing pathogen-associated molecular patterns (PAMPs),
which in yeasts consist of cell wall components -1,3-glucan,
mannoproteins, and chitin, from the host’s pattern recognition
receptors (PRRs). An additional mechanism to avoid phagocyto-
sis consists of preventing opsonization, as described, for example,
for C. albicans and Cryptococcus neoformans (20). Survival and
escape following phagocytosis depend on additional adaptations.
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Yeasts undergo massive transcriptional adjustments allowing
them to adapt to the hostile conditions within the phagolysosome,
and they are able to inhibit phagosome maturation and the oxi-
dative burst mounted by phagocytes (20). In C. glabrata, the abil-
ity to escape immune control and persist in the host for long
periods of time is not fully understood. To our knowledge, no
mechanism of evasion from phagocytosis has so far been identi-
fied.However,C. glabrata is clearly able to survive phagocytosis by
cells of the innate immune system and even replicate within
phagocytes (21–23). The transcriptional adaptations of C.
glabrata in the phagolysosome appear to be similar to those of C.
albicans (22). Recycling of endogenous cellular components
through autophagy (21) and oxidative stress resistance (24) also
seem to play important roles. Additionally, recent work by Seider
et al. showed that C. glabrata counteracts phagosome maturation
and cytokine production to persist within macrophages (23). In-
terestingly, a family of glycosylphosphatidylinositol (GPI)-linked
aspartyl proteases called yapsins have also been shown to contrib-
ute to C. glabrata virulence and impact their survival within mac-
rophages (22). By remodeling the cell wall through removal of
GPI-anchored cell wall proteins, yapsins are implicated in cell wall
integrity and, ultimately, virulence in C. glabrata (22). Another
interesting activity may be the control of adherence to mamma-
lian cells, through removal of GPI-anchored cell wall adhesins
(22). A dynamic control of the presentation of such adhesins at the
cell surface appears to be important, rather than their constitutive
expression.
In the present work, we addressed the impact of CgPDR1GOF
mutations on the interaction of C. glabrata with host cells. We
hypothesize that the modulation of the interaction with host cells
may contribute to the previously foundCgPDR1-mediated gain of
virulence in C. glabrata. To address this problem, we performed
competitive coculture experiments of C. glabrata strains harbor-
ing different CgPDR1 alleles with primary murine macrophages
and human cell line-derivedmacrophages as well as with different
epithelial cells. We investigated adherence and uptake of C.
glabrata by host cells, as well as survival and replication following
phagocytosis. Our results reveal that CgPDR1 modulates the in-
teraction of C. glabrata with mammalian cells.
MATERIALS AND METHODS
Strains and growth media. The C. glabrata strains used in this study are
listed in Table 1. Clinical isolates and strains with the prefix SFY are from
previously published collections (13, 14). Strains were stored in 20% glyc-
erol stocks at 80°C and cultured on either YPD (1% yeast extract, 2%
peptone, 2% D-glucose) or appropriate selective media at 30°C. Selective
media for growth of transformed strains were either YPD containing 200
g/ml of nourseothricin (clonNAT;Werner BioAgents, Germany) or 600
g/ml of hygromycin B (PAA Laboratories, Austria); additionally, YNB
minimal medium (0.67% yeast nitrogen base plus 2% glucose) with ap-
propriate amino acids and bases and without uracil was used for uracil
prototrophs. For solid media, 2% agar was added. YPD containing 30
g/ml of fluconazole (Pfizer) was used when appropriate. Escherichia coli
DH5was used as a host for plasmid construction andpropagation.E. coli
DH5 was grown in Luria-Bertani broth or on Luria-Bertani agar plates,
supplemented with ampicillin (0.1 mg/ml) when required.
Disruption of CgURA3. Uracil auxotrophs of all strains used in this
study were constructed through targeted gene disruption of CgURA3.
Briefly, the complete CgURA3 open reading frame (ORF) flanked by 500
bp was amplified by PCR from genomic DNA of strain DSY562, using
primers CgURA3-KpnI (5=-GTA GGG TAC CTC ATA TCT TGT CAC
TAT ATA-3=) and CgURA3-SpeI (5=-GCA AAC TAG TGC AAT AAA
GGA TGC AAA AC-3=), and inserted into pBluescript II KS() to gener-
ate pVS12. This plasmid was amplified by PCR using the primers
CgURA3-Inv-SalI (5=-AAA AGT CGA CTG GGA TGC TTA CTT GAA
AAG-3=) and CgURA3-Inv-BamHI (5=-TGG AGG ATC CAC TAA TCT
ACTGGGATGATG-3=). The resulting PCR product was digested by SalI
and BamHI and ligated to a 2.1-kb SalI/BamHI fragment from pAP599
containing the hph expression cassette (FRT-ScPGK1p-hph-3=UTR
ScHIS3-FRT; conferring resistance to hygromycin B) (25). The resulting
plasmid (pVS13) was digested by SpeI and KpnI and used to transform all
test strains by an adapted lithium acetate (LiAc) procedure (26). Resulting
ura3 transformants were selected on hygromycin B-containing YPD
plates incubated for 2 to 3 days at 35°C and confirmed by PCR.
Labelingwith fluorescent proteins.A set of plasmidswas constructed
to label C. glabrata strains with fluorescent proteins. Briefly, pGRB2.3, a
CgCEN/ARSURA3 plasmidmade by introducing a yeast-enhanced green
fluorescence protein (GFP) expression cassette (ScPGK1p-yEGFP-ScHIS3
3=UTR) in plasmid pGRB2.2 (27), was used for labeling strains with GFP.
Yeast-enhancedmonomeric red fluorescent protein (RFP) (yEmRFP) was
obtained from an available plasmid in our collection, pCgACU-TDH3p-
cherry (ScTDH3p-yEmRFP), previously constructed by ligating two
KpnI/BamHI fragments consisting of the CgCEN/ARS URA3 backbone
from plasmid pCgACU-5 (28) and yEmRFP from plasmid yEpGAP-
Cherry (29). yEmRFP was amplified by PCR from pCgACU-TDH3p-
cherry using primers TDH3p-GFP (5=-CAC CAA GAA CTT AGT TTC
G-3=) and RFP-XhoI (5=-TGA ACT CGAGCT CGG TACCTT ATT TAT
ATA ATT C-3=), digested by EcoRI and XhoI, and ligated to an EcoRI/
XhoI fragment from pGRB2.3, thus generating the replacement of yEGFP
by yEmRFP (pVS19). An empty control plasmid was constructed by cut-
ting out yEGFP with AvaI, blunting the DNA sticky ends using T4 DNA
polymerase, and ligating the blunt ends together (pVS20; ScPGK1p-
ScHIS3 3= UTR). C. glabrata ura3 strains were transformed with the
three plasmids by an adapted LiAc procedure (26). Transformants were
selected based on reversion to uracil prototrophy after growth for 2 to 3
days at 35°C in YNBminimal medium with appropriate amino acids and
bases and without uracil.
Macrophage culture and infection for yeast replication assays.Bone
marrow was extracted from both femurs and tibiae of 8- to 10-week-old
female BALB/c mice (approximately 20 g; the mice were obtained from
Charles River Laboratories, France, and housed in filter top cageswith free
access to food and water, under the surveillance of the local governmental
veterinarian offices, Affaires Vétérinaires du Canton de Vaud, Switzer-
land; authorization number 2240). A bone marrow cell suspension was
filtered through a 40-m cell strainer filter and suspended in culture
medium (high-glucose Iscove’s modified Dulbecco’s medium with
GlutaMAX [IMDM]; Life Technologies), supplementedwith 100U/ml pen-
icillin and 100 g/ml streptomycin (Life Technologies), 10% fetal bovine
serum (FBS; Life Technologies), and 20% L-cell-conditionedmedium (as
a source of macrophage colony-stimulating factor [M-CSF]). Cells were
seeded into 150- by 20-mm petri dishes (Sarstedt) at 4  106 cells/plate
and incubated at 37°C in the presence of 5% CO2. Cultures were fed by
adding fresh medium after 2 and 4 days of incubation. After 6 days of
incubation, bone marrow-derived macrophages (BMDMs) that selec-
tively adhered to the dishes were harvested with the nonenzymatic solu-
tion Versene (Life Technologies) and transferred to 24-well plates at a
density of 3.0 105 cells/well in 1 ml of medium (IMDMwith antibiotics
and 10% FBS). Yeast strains were ura3 strains carrying either GFP/RFP-
expressing plasmids or empty control plasmids (reconstituting the ura3
deletion), and inoculum concentrations were confirmed by plating serial
dilutions in YPD agar plates. After an additional 20- to 24-h incubation,
preconfluent BMDM monolayers were used to perform fungal competi-
tion assays. To prepare C. glabrata suspensions for infection, overnight
cultures of fluorescent protein-labeled or empty plasmid control strains in
selective medium were diluted in fresh medium and grown for a mini-
mum of 2 generations to mid-log phase. Log-phase cells were washed and
resuspended in phosphate-buffered saline solution (PBS). For staining
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with superficial stains, yeasts were washed and resuspended in carbonate
buffer (0.1 M Na2CO3, 0.15 M NaCl, pH 9.0), stained with fluorescein
isothiocyanate (FITC; Thermo Scientific) or tetramethylrhodamine iso-
thiocyanate (TRITC; Thermo Scientific) for 30 min at 37°C at final con-
centrations of 100g/ml and 10g/ml, respectively, and thenwashed and
resuspended in PBS.Macrophage cultures were infected with either single
or 1:1 mixed yeast strain suspensions at a multiplicity of infection (MOI)
of 1 (according to the macrophage seeding density), and the plates were
centrifuged at 200 g for 1min. Cocultures were incubated at 37°C in 5%
CO2, and at selected time points non-macrophage-associated yeasts were
removed bywashing. Yeasts were recovered by lysis of themacrophages in
0.1%Triton X-100 and plated onto YPD plates for quantification of CFU.
YPD agar and YPD agar plates containing 30 g/ml of fluconazole were
used to distinguish between azole-susceptible and azole-resistant yeast
TABLE 1 Strains used in this study
Strain Parental strain Plasmid used Description or relevant genotype Reference
DSY562 Azole-susceptible clinical strain 13
DSY565 Related to DSY562 Azole-resistant clinical strain 13
SFY114 SFY93 DSY562 pdr1::PDR1-SAT1 13
SFY115 SFY93 DSY562 pdr1::PDR1L280F-SAT1 13
VSY21 DSY562 pVS13 ura3::hph This study
VSY22 DSY565 pVS13 ura3::hph This study
VSY33 VSY21 pCgACU-TDH3p-GFP DSY562 ura3::hph, ScTDH3p-yEGFP(3), URA3, CEN-ARS This study
VSY38 SFY153 pVS13 DSY565 cdr1::FRT, ura3::hph This study
VSY40 SFY155 pVS13 DSY565 pup1::FRT, ura3::hph This study
VSY42 SFY170 pVS13 DSY565 cdr1::FRT, pup1::SAT1, ura3::hph This study
VSY43 SFY114 pVS13 DSY562 pdr1::PDR1-SAT1, ura3::hph This study
VSY44 SFY115 pVS13 DSY562 pdr1::PDR1L280F-SAT1, ura3::hph This study
VSY55 VSY21 pGRB2.3 DSY562 ura3::hph, ScPGK1p-yEGFP, URA3, CEN-ARS This study
VSY56 VSY22 pGRB2.3 DSY565 ura3::hph, ScPGK1p-yEGFP, URA3, CEN-ARS This study
VSY57 VSY21 pVS19 DSY562 ura3::hph, ScPGK1p-yEmRFP, URA3, CEN-ARS This study
VSY58 VSY22 pVS19 DSY565 ura3::hph, ScPGK1p-yEmRFP, URA3, CEN-ARS This study
VSY59 VSY21 pVS20 DSY562 ura3::hph, ScPGK1p, URA3, CEN-ARS This study
VSY60 VSY22 pVS20 DSY565 ura3::hph, ScPGK1p, URA3, CEN-ARS This study
VSY65 VSY38 pVS20 DSY565 cdr1::FRT, ura3::hph, ScPGK1p, URA3, CEN-ARS This study
VSY66 VSY40 pVS20 DSY565 pup1::FRT, ura3::hph, ScPGK1p, URA3, CEN-ARS This study
VSY67 VSY42 pVS20 DSY565 cdr1::FRT, pup1::SAT1, ura3::hph, ScPGK1p, URA3, CEN-ARS This study
VSY68 VSY38 pGRB2.3 DSY565 cdr1::FRT, ura3::hph, ScPGK1p-yEGFP, URA3, CEN-ARS This study
VSY69 VSY40 pGRB2.3 DSY565 pup1::FRT, ura3::hph, ScPGK1p-yEGFP, URA3, CEN-ARS This study
VSY70 VSY42 pGRB2.3 DSY565 cdr1::FRT, pup1::SAT1, ura3::hph, ScPGK1p- yEGFP, URA3,
CEN-ARS
This study
VSY71 VSY38 pVS19 DSY565 cdr1::FRT, ura3::hph, ScPGK1p- yEmRFP, URA3, CEN-ARS This study
VSY72 VSY40 pVS19 DSY565 pup1::FRT, ura3::hph, ScPGK1p, yEmRFP, URA3-CEN-ARS This study
VSY73 VSY42 pVS19 DSY565 cdr1::FRT, pup1::SAT1, ura3::hph, ScPGK1p-yEmRFP, URA3,
CEN-ARS
This study
VSY101 VSY43 pVS20 DSY562 pdr1::PDR1-SAT1, ura3::hph, ScPGK1p, URA3, CEN-ARS This study
VSY102 VSY44 pVS20 DSY562 pdr1::PDR1L280F-SAT1, ura3::hph, ScPGK1p, URA3, CEN-ARS This study
VSY103 VSY43 pGRB2.3 DSY562 pdr1::PDR1-SAT1, ura3::hph, ScPGK1p-yEGFP, URA3, CEN-ARS This study
VSY104 VSY44 pGRB2.3 DSY562 pdr1::PDR1L280F-SAT1, ura3::hph, ScPGK1p-yEGFP, URA3, CEN-ARS This study
VSY105 VSY43 pVS19 DSY562 pdr1::PDR1-SAT1, ura3::hph, ScPGK1p-yEmRFP, URA3, CEN-ARS This study
VSY106 VSY44 pVS19 DSY562 pdr1::PDR1L280F-SAT1, ura3::hph, ScPGK1p-yEmRFP, URA3, CEN-ARS This study
VSY119 SFY93 pVS13 DSY562 pdr1::FRT, ura3::hph This study
VSY120 SFY95 pVS13 DSY565 pdr1::FRT, ura3::hph This study
VSY121 VSY119 pVS20 DSY562 pdr1::FRT, ura3::hph, ScPGK1p, URA3, CEN-ARS This study
VSY122 VSY120 pVS20 DSY565 pdr1::FRT, ura3::hph, ScPGK1p, URA3, CEN-ARS This study
VSY123 VSY119 pGRB2.3 DSY562 pdr1::FRT, ura3::hph, ScPGK1p-yEGFP, URA3, CEN-ARS This study
VSY124 VSY120 pGRB2.3 DSY565 pdr1::FRT, ura3::hph, ScPGK1p-yEGFP, URA3, CEN-ARS This study
VSY125 VSY119 pVS19 DSY562 pdr1::FRT, ura3::hph, ScPGK1p-yEmRFP, URA3, CEN-ARS This study
VSY126 VSY120 pVS19 DSY565 pdr1::FRT, ura3::hph, ScPGK1p-yEmRFP, URA3, CEN-ARS This study
VSY132 SFY101 pVS13 DSY562 pdr1::PDR1R376W-SAT1, ura3::hph This study
VSY133 SFY105 pVS13 DSY562 pdr1::PDR1T588A-SAT1, ura3::hph This study
VSY134 VSY132 pVS20 DSY562 pdr1::PDR1R376W-SAT1, ura3::hph, ScPGK1p, URA3, CEN-ARS This study
VSY135 VSY133 pVS20 DSY562 pdr1::PDR1T588A-SAT1, ura3::hph, ScPGK1p, URA3, CEN-ARS This study
VSY136 VSY132 pGRB2.3 DSY562 pdr1::PDR1R376W-SAT1, ura3::hph, ScPGK1p-yEGFP, URA3, CEN-ARS This study
VSY137 VSY133 pGRB2.3 DSY562 pdr1::PDR1T588A-SAT1, ura3::hph, ScPGK1p-yEGFP, URA3, CEN-ARS This study
VSY138 VSY132 pVS19 DSY562 pdr1::PDR1R376W-SAT1, ura3::hph, ScPGK1p-yEmRFP, URA3,
CEN-ARS
This study
VSY139 VSY133 pVS19 DSY562 pdr1::PDR1T588A-SAT1, ura3::hph, ScPGK1p-yEmRFP, URA3,
CEN-ARS
This study
Host Interactions with C. glabrata
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strains. Alternatively, cocultures established on top of round cover slides
were mounted onto microscopy slides and observed using a Zeiss
Axioplan 2 epifluorescence microscope (images were recorded using a
Visitron Systems HistoScope Camera and VisiView Imaging Software).
Macrophage culture and infection for yeast adherence and phago-
cytosis assays. BMDM cultures established in 24-well plates on top of
round cover slides as described above were infected with 1:1 mixed yeast
suspensions at an MOI of 0.6, 2, or 6, and the plates were centrifuged at
200  g for 1 min. For adherence experiments, BMDM cultures were
treated with 1.0 M cytochalasin D at 37°C in 5% CO2 starting 30 min
before infection and then throughout coincubation. To test the influence
of galactose, the culture medium was replaced by fresh medium contain-
ing from 0.5 to 10 mM galactose before infection. Cocultures were incu-
bated at 37°C in 5% CO2, and at selected time points non-macrophage-
associated yeasts were removed by washing. Cocultures were stained with
100g/ml of calcofluor white (CW; Sigma) for 10min andmounted onto
microscopy slides for epifluorescence microscopy as described above.
For human acute monocytic leukemia cell line (THP-1; ATCC TIB-
202)-derived macrophages, log-phase THP-1 cell cultures in suspension
in high-glucose RPMI 1640mediumwith GlutaMAX (Life Technologies)
supplemented with 100 U/ml penicillin, 100 g/ml streptomycin (Life
Technologies), and 10%FBS (Life Technologies) were seeded into 24-well
plates on top of round cover slides at a density of 5.0 105 cells/well in 1
ml of the samemedium. Differentiation and attachment were induced by
adding 20 nM phorbol 12-myristate 13-acetate (PMA; Sigma). After 48 h
of incubation at 37°C in 5% CO2, preconfluent THP-1-derived macro-
phage-like cell monolayers were washed, and fresh culture medium was
added. Cultures were infected with 1:1 mixed yeast suspensions contain-
ing 6.0 105 yeast cells, prepared as described above, and the plates were
centrifuged at 200  g for 1 min. For adherence experiments, THP-1-
derived macrophage-like cells were treated with cytochalasin D as de-
scribed above for BMDMs. Cocultures were stained with CW and ob-
served under epifluorescence microscopy as described.
Cytokine production.BMDMcultures established as described above
were seeded in 96-well plates at a density of 1.0 105 cells/well in 0.2 ml
of IMDM with 10% FBS. Cultures were infected with either single-strain
or 1:1 mixed yeast strain suspensions, prepared as described above, at an
MOI of 3, 1, or 0.3. The plates were centrifuged at 200 g for 1 min and
incubated at 37°C in 5% CO2. After 1.5 h of incubation, 2.5 g/ml of
amphotericin B was added to all wells (including the uninfected controls)
to prevent yeast overgrowth. At 24 h the plates were centrifuged, and
supernatants were transferred to new plates. Cytokines were quantified by
standard enzyme-linked immunosorbent assay (ELISA) techniques using
purified anti-interleukin 12p40 (anti-IL-12p40) (clones 15.6) or anti-tu-
mor necrosis factor (anti-TNF) (clone 6B8) for coating and biotinylated
anti-IL-12p40 (clone C17.8) or anti-TNF (clone MP6-XT22) combined
with Extravidin-alkaline phosphatase (Sigma) and p-nitrophenyl phos-
phate substrate (Sigma) for detection. IL-1productionwas quantified by
BD cytometric bead array according to the manufacturer’s instructions
(BD Biosciences).
Yeast adherence to epithelial cells. Epithelial cell lines Chinese ham-
ster ovary modified cell line Lec2 (CHO-Lec2; ATCC CRL1736), human
cervix adenocarcinoma cells (CHO-HeLa; ATCC CCL-2), and human
colorectal adenocarcinoma cells (Caco-2; ATCC HTB-37) were em-
ployed. CHO-Lec2 cells were cultured in high-glucoseminimumessential
medium  (MEM-; Life Technologies), while HeLa and Caco-2 cells
were cultured in Dulbecco’s modified Eagle medium (DMEM; Life Tech-
nologies). Bothmedia included L-glutamine and were supplemented with
100 U/ml penicillin, 100 g/ml streptomycin (Life Technologies), and
10% FBS (Life Technologies). Log-phase epithelial cells were seeded in
24-well plates at a density of 1.0 105 cells/well in 1ml of culturemedium
and allowed to grow to full confluence at 37°C in 5%CO2, typically for 48
to 72 h. Epithelial cell monolayers were infected with 1:1 mixed yeast
suspensions containing 3.0 105 yeast cells, prepared as described earlier,
and the plates were centrifuged at 200  g for 1 min. Cocultures were
incubated at 37°C in 5% CO2 for 30 min, and nonadherent yeasts were
removed by washing. Adherent yeasts were recovered by lysis of the epi-
thelial cells in 0.1% Triton X-100 and plated onto YPD agar plates for
quantification of CFU. YPD agar alone and YPD agar plates containing 30
g/ml of fluconazole were used to distinguish between azole-susceptible
and azole-resistant yeast strains.
RESULTS
CgPDR1 hyperactivity does not affect survival and replication
inside BMDMs. In a previous study, we found that azole resis-
tance mediated by CgPDR1 hyperactivity in C. glabrata led to in-
creased fitness in vivo and increased virulence inmurinemodels of
disseminated infection (13). A follow-up report revealed that the
ABC transporter CgCdr1 and the mitochondrial protein Pup1
partially contributed to this phenotype (14). To investigate the
mechanism behind the gain of virulencemediated byCgPDR1, we
set up ex vivo coculture experiments with primary BMDMs as a
model of the interaction of C. glabrata with the innate cellular
immune response. We used fluorescent protein-labeled yeasts
withGFP or RFP expressed from episomal plasmidswith selection
based onURA3 complementation of uracil auxotrophy. As shown
in Fig. 1, in strains constructed on the DSY562 strain background,
fluorescent protein expression did not affect growth in compari-
son to empty vector control strains. The samewas true for all other
strains (data not shown). Additionally, we stained test strains with
the fluorescent dye FITC or TRITC prior to inoculation, to be able
to track the division of the yeasts within BMDMs after phagocy-
tosis. Since the fluorescent dyes do not propagate to daughter cells
during replication, this allows the identification of newly divided
cells. BMDM cultures were inoculated with C. glabrata strains
DSY562 and DSY565, an azole-susceptible clinical isolate and its
matched isolate with a GOFmutation on CgPdr1 (L280F) leading
to azole resistance and increased virulence (13). Nonstained yeast
cell buds resulting from intracellular growth inside BMDMs first
became visible after 5 h of coincubation (Fig. 2A). At 24 h of
coincubation many nonstained yeasts could be observed, and in
some cases BMDMs were completely filled with C. glabrata
(Fig. 2A). This result was indistinguishably observed for both
strains DSY562 and DSY565. Continuing the coincubation for
periods longer than 24 h allowed the continuousmultiplication of
the yeasts. This eventually resulted in the disruption of the phago-
FIG 1 Growth curves of C. glabrata strains labeled with fluorescent proteins.
The test strains were grown overnight and diluted to a density of 5.0  104
cells/ml in selective medium (YNB minimal medium with appropriate amino
acids and bases and without uracil). Cultures were grown under constant
agitation at 30°C, and growth was determined at 2-h intervals from 14 h to 24
h bymeasuring the absorbance at 540 nm. The test strains were isogenic strains
on the DSY562 strain background harboring episomal plasmids expressing
ScPGK1p-yEGFP (VSY55 o), ScPGK1p-yEmRFP (VSY57 p), or the empty
vector (VSY59Œ).
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cytic cell, which left behind a yeast microcolony on the cell culture
plates. Again, there was no apparent difference between the two
strains. To quantify the replication of the yeasts, we performed
similar experiments in which the readout was changed to lysing
the BMDMs and plating the resulting yeast suspensions onto solid
media to count CFU. Ratios between counts obtained 2 h after
inoculation and the inocula revealed that most yeasts (around
70%of the inocula) remained associated to BMDMs after washing
the coculture. The ratios were somewhat lower for strain DSY565
than for DSY562 (Fig. 2B, 2 h ratios), although the differences did
not reach statistical significance. Ratios between CFU counts at 24
h and 2 h were similar in all cases, thus illustrating a similar ability
to replicate inside BMDMs for the two strains (Fig. 2C).
CgPDR1 hyperactivity does not affect cytokine production
by BMDMs. The production of proinflammatory cytokines by
phagocytes is an important response of the host to infection. To
investigate the impact of CgPDR1 hyperactivity on cytokine pro-
duction, wemeasured concentrations of TNF-, IL-12, and IL-1
in the culture medium following 24 h of coincubation of C.
glabrata with BMDMs. We could not detect any differences be-
tween strains DSY562 and DSY565 or the isogenic strains ob-
tained by deletingCgPDR1 on the DSY562 strain background and
reintroducing either the wild-type (DSY562 pdr1::PDR1) or the
hyperactive CgPDR1 allele (DSY562 pdr1::PDR1L280F) (13)
(Fig. 3 and data not shown). Using mixed inocula of 1:1 suspen-
sions of strains DSY562 andDSY565 or the isogenic pair of strains
at the same MOIs resulted in similar outcomes (data not shown).
Given the similar host response upon stimulation with the two C.
glabrata cell types, our results rule out an influence of this step of
the yeast-host interaction on the differential virulence attributed
to CgPDR1 hyperactivity.
CgPDR1 hyperactivity leads to a decrease in competitive up-
take ofC. glabrata by BMDMs. The ability to evade phagocytosis
is a strategy employed by different pathogenic microorganisms to
escape the host’s immunity. To specifically investigate this step of
the interaction between yeasts and phagocytes, we set up compe-
tition experiments using fluorescent protein-labeled yeasts in co-
culture with BMDMs. The competition design was chosen be-
cause of its ability to uncover subtle phenotypic differences that
might otherwise be missed in single-strain experiments. Mixed
suspensions including GFP-expressing DSY562 and RFP-express-
ing DSY565 strains and vice versa were used to inoculate precon-
fluent BMDM monolayers. Cocultures were stained at different
time points with the chitin-binding dye calcofluor white (CW),
which does not penetrate viable phagocytes and thus stains
noninternalized yeasts only. We next observed yeast cells under
epifluorescence microscopy (Fig. 4A). Counting internalized
GFP- and RFP-labeled yeast cells revealed lower numbers of
phagocytosed DSY565 cells, expressed as percentages of each
strain in the total number of yeasts, or percent internalization
ratios (PIR; Fig. 4B). This differencewas statistically significant for
all time points, ranging from 30 min up to 4 h of coincubation.
FIG 2 Replication of C. glabrata inside BMDMs following phagocytosis. (A)Microscopy images of three representative examples acquired following 5 h and 24
h of coincubation ofC. glabrataDSY565 with BMDMs. Log-phase cultures of RFP-labeled yeasts (VSY58) were stained with FITC, as described inMaterials and
Methods, and added to preconfluent BMDMmonolayers (established on top of round cover slides in 24-well plates) at anMOI of 1. Cocultures were incubated
in IMDM at 37°C in 5%CO2 andmounted onto microscopy slides at selected time points for visualization. Since the FITC stain does not propagate to daughter
cells during budding, the absence of FITC staining denotes yeast cells resulting from replication inside BMDMs. Bar, 10 m. DIC, differential interference
contrast. (B) Two-hour and 24-h inoculum CFU count ratios. Log-phase C. glabrata (VSY59 and VSY60) cultures containing either a single strain (single
inoculum) or a 1:1 mix of two strains (mixed inoculum) were added to preconfluent BMDMmonolayers at anMOI of 1. After 2 h of coincubation, the cultures
were washed to remove noninternalized yeast cells. Immediately following the washes, as well as after 24 h of coincubation, BMDMs were lysed and dilutions of
the resulting yeast suspensions were plated onto solid medium. (C) Count ratios (24-h CFU/2-h CFU) of the data displayed in panel B. Results on panels B and
C aremeans standard deviations (SD) of aminimumof three independent experiments.P values of0.05were considered significant, and differences between
strains DSY562 and DSY565 are not statistically significant (P	 0.05, unpaired Student’s t test).
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PIR values were around 60% and 40% for DSY562 and DSY565,
respectively. No significant influence of the incubation time was
found. Similar experiments performed with a DSY562-derived
isogenic strain pair resulted in similar PIR differences after 2 h of
incubation (Fig. 4C), thus confirming that the L280F GOF muta-
tion on CgPdr1 was responsible for the difference. A difference
was also observed when using 3-fold lower or higher MOIs
(Fig. 4C). Even at an MOI of 6, the difference between the two
strains was still observed. Control experiments testing the same
strain labeled with GFP or RFP resulted in PIRs of around 50%
(Fig. 4D) and thus ruled out an influence of the fluorescent pro-
tein. To investigate the role of the CgPdr1 targets CgCdr1 and
Pup1, which were previously found to contribute to CgPdr1-me-
diated gain of virulence (14), we performed additional experi-
ments comparing strain DSY565 with the corresponding mutants
on the same strain background. Significant differences in PIRwere
found between DSY565 and the cdr1 pup1 double mutant, but
no difference was detected for either of the two single mutants
(Fig. 4E). Taken together, our results revealed a bias toward de-
creased phagocytosis of strains containing the hyperactive
CgPDR1L280F allele in competition with strains with the wild-type
CgPDR1. The CgPdr1 targets CgCDR1 and PUP1 may both con-
tribute to this difference.
CgPDR1 hyperactivity leads to decreased adherence to
BMDMs.Given the described differences in phagocytosis between
distinct C. glabrata isolates, we next addressed whether or not the
CgPDR1 allele was able to influence the adherence step preceding
phagocytosis. We performed similar coculture experiments in a
medium containing the actin polymerization inhibitor cytochala-
sin D to inhibit phagocytosis. Preconfluent BMDM cultures were
incubated for 30 min in cytochalasin D and then inoculated with
mixed suspensions of the yeast strains as for the above-described
phagocytosis experiments. Cytochalasin D has been used before
without causing any general adverse effects tomammalian cells or
Candida species yeasts (30). After 1 h of coincubation, nonadher-
ent yeasts were washed, and cultures were observed under epiflu-
orescence microscopy. CW staining was used to confirm that
yeasts adhering to BMDMswere not internalized. Visual counts of
GFP- and RFP-labeled yeast cells were lower for strains exhibiting
the hyperactive allele CgPDR1L280F. The determined percent ad-
herence ratios (PAR; Fig. 5A) closely resembled corresponding
PIRs. Again, experiments with mixed inocula of the same strain
separately labeled with GFP and RFP revealed no difference and
thus no influence of the fluorescent protein labeling on adherence
(PARs of around 50%; Fig. 5B). Unlike what was observed for
phagocytosis, testing cdr1 and pup1 mutants on the DSY565
strain background did not reveal significant differences of adher-
ence (Fig. 5C). This suggests that CgCdr1 and Pup1 may interfere
with the phagocytosis step only.
Additional hyperactive CgPDR1 alleles reproduce interac-
tion phenotypes with BMDMs. To determine if the discovered
adherence and phagocytosis phenotype was dependent on
CgPDR1L280F or rather related to CgPDR1 hyperactivity per se, we
tested additional hyperactive CgPDR1 alleles in the same phago-
cytosis/adherence assay. A group of isogenic strainswas used, con-
structed by reintroducing in a DSY562 pdr1 background either
the wild-type (DSY562 pdr1::CgPDR1) or the hyperactive
CgPDR1 alleles with GOFmutations L280F from DSY565 (DSY562
pdr1::CgPDR1L280F), R376W from DSY739 (DSY562 pdr1::
CgPDR1R376W), and T588A from DSY2234 (DSY562 pdr1::
CgPDR1T588A) (13). These two additional hyperactive alleles
tested in competition with the wild type were found to cause a
decrease similar to that caused by PDR1L280F in uptake (Fig. 6A)
and adherence to BMDMs (Fig. 6B). Allele PDR1R376W has been
previously shown to cause a similar pattern of target gene overex-
pression to PDR1L280F, based mainly on CgCDR1, while allele
PDR1T588A displays a different pattern, rather based on CgCDR2
overexpression (13). Nevertheless, and just as previously observed
for gain of virulence in mouse models of systemic infection, these
two additional alleles both recapitulated the CgPDR1L280F-medi-
ated phenotypes in what regards their interaction with BMDMs.
CgPDR1-mediated differences in the interaction with
BMDMs are reproduced with THP-1-derived macrophage-like
cells. To investigate whether the uncovered phenotype could be
reproduced using different phagocytic cells, we repeated the co-
culture experiments with humanmacrophages.We used the acute
monocytic leukemia cell line THP-1 differentiated into adherent
macrophage-like cells. Phagocytosis experiments yielded results
similar to those obtained with BMDMs. In fact, resulting PIRs
were indistinguishable from those obtained following coincuba-
tion with BMDMs (Fig. 7A). Adherence experiments to THP-1-
derived phagocytes treated with cytochalasin D resulted in con-
siderably lower numbers of adherent yeasts than those seen with
BMDMs. Under our experimental conditions, adhesion indexes
(AI; representing the number of adherent yeasts per 100 phago-
cytic cells) to BMDMs approached 300 and 200 for the wild type
and the hyperactive CgPDR1L280F allele, respectively. These in-
dexes were about 8-fold lower with THP1-derived cells. However,
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FIG 3 Cytokine release by BMDMs in response to C. glabrata strains. Precon-
fluent BMDM monolayers were infected with the matched clinical isolates
DSY562 and DSY565 and with isogenic strains on the DSY562 strain back-
ground harboring either its original CgPDR1 wild-type allele (PDR1; SFY114)
or the hyperactiveCgPDR1L280F allele fromDSY565 (L280F; SFY115). At 24 h,
TNF- (A) and IL-12 (B) levels in the supernatantswere determined by ELISA.
Results are means SD of triplicate infections and are representative of three
independent experiments. Differences between strains are not statistically sig-
nificant (P	 0.05, one-way analysis of variance [ANOVA]). uninf, uninfected.
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FIG4 Phagocytosis ofC. glabrata by BMDMs. (A) Representativemicroscopy images acquired following 2 h of coincubation ofC. glabrata strains with BMDMs.
Log-phase cultures of yeast strainsDSY562 andDSY565 labeledwithGFP andRFP (VSY55 toVSY58)weremixed and added to preconfluent BMDMmonolayers
(established on top of round cover slides) at an MOI of 1 for each of the two yeast strains (total MOI, 2). At selected time points, cultures were stained with
calcofluor white (CW) and the round cover slides were mounted onto microscopy slides for visualization. The chitin-binding stain CW does not penetrate
BMDMs and thus stains noninternalized yeasts only. Bar, 20 m. DIC, differential interference contrast. (B) Quantification of competitive uptake of matched
clinical isolates DSY562 and DSY565 by BMDMs. Cultures were prepared and visualized as described for panel A. A minimum of 100 BMDMs and internalized
green and red yeast cells were counted and expressed as percent internalization ratios (PIRs; percentage of yeasts of each strain in the total number of yeasts from
both competitor strains). (C) PIRs determined as described for panel B after 2 h of coincubation. Yeasts are isogenic strains on the DSY562 strain background
harboring either its original CgPDR1 wild-type allele (PDR1) or the hyperactive CgPDR1L280F allele from DSY565 (L280F; VSY103 to VSY106). Strains were
inoculated at anMOI of 0.3, 1, or 3 for each of the two yeast strains (total MOI, 0.6, 2, or 6). (D) Control PIRs determined as described for competitions between
the same clinical isolate labeled with the two different fluorescent proteins. (E) PIRs determined as described for competitions between clinical isolate DSY565
(VSY56 and VSY58) and either cdr1, pup1, or cdr1 pup1 double mutant strains constructed on the same strain background (VSY68 to VSY73). Results on
panels B throughE aremeans SDof aminimumof three independent experiments performed in duplicate (with fluorescent protein labeling swapping between
strains). Statistical analysis of the differences between PIRs on panel B was performed using repeated-measures 2-way ANOVA on data transformed to global
ranks, followed by Bonferroni’s posttest for selected pairwise comparisons (no significant influence of the incubation time was found; for strain, P 0.0001; for
time, P 
 1.000; for the time-strain interaction, P 
 0.1230). For panels C, D, and E, differences between PIRs in strain pairs were analyzed using the
Mann-WhitneyU test.P values of0.05were considered significant, and asterisks representP value ranges (ns,P	 0.05; *,P 0.05; **,P 0.01; ***,P 0.001).
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a decreased adherence of strains containing the hyperactive allele
was still observed, with PAR values similar to PIRs (Fig. 7B). Re-
peating the experiments with THP-1-derived phagocytic cells
fixed in formaldehyde instead of using cytochalasinD-treated cul-
tures produced similar results (data not shown).
CgPDR1 hyperactivity favors adherence to epithelial cells.
Given the decreased uptake by and adherence to phagocytes in C.
glabrata strains with hyperactive CgPDR1 alleles, we wondered
whether similar differencesmight be found in the interactionwith
other host cell types. Adherence to host epithelial surfaces is a key
step in the host-pathogen interaction and is required for the suc-
cessful establishment of colonization and infection by yeasts. This
way, we tested the role of CgPDR1 on the adherence to epithelial
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FIG 5 Adherence of C. glabrata to BMDMs. The test strains were matched
clinical isolatesDSY562 andDSY565 and isogenic strains on theDSY562 strain
background harboring either its original CgPDR1 wild-type allele (PDR1) or
the hyperactive CgPDR1L280F allele from DSY565 (L280F). (A) Quantification
of competitive adherence to BMDMs. Experimental conditionswere similar to
those described for phagocytosis experiments in legend to Fig. 4C, with the
exception that they were performed with 1 h of coincubation in medium con-
taining 1.0 M cytochalasin D to inhibit phagocytosis. Percent adherence
ratios (PARs) represent percentages of yeasts of each strain in the total number
of yeasts from both competitor strains. (B) Control PARs determined as de-
scribed for competitions between the same clinical isolate labeled with the two
different fluorescent proteins. (C) PARs determined as described for compe-
titions between clinical isolate DSY565 and either cdr1, pup1, or cdr1
pup1 double mutant strains constructed on the same strain background.
Results are means  SD of a minimum of three independent experiments
performed in duplicate (with fluorescent protein labeling swapping between
strains). Statistical analyses of the differences between PARs for each pair of
competitor strainswere performedusing theMann-WhitneyU test for panel A
and the unpaired Student t test for panels B and C. P values of 0.05 were
considered significant, and asterisks represent P value ranges (ns, P	 0.05; *,
P 0.05; **, P 0.01).
FIG 6 Phagocytosis and adherence of C. glabrata to BMDMs. The test strains were isogenic strains constructed on the DSY562 strain background harboring
either its original CgPDR1 wild-type allele (Cgpdr1::CgPDR1; PDR1, VSY103 and VSY105) or hyperactive alleles CgPDR1L280F from DSY565 (L280F, VSY104
and VSY106), CgPDR1R376W fromDSY739 (R376W, VSY136 and VSY138) and CgPDR1T588A fromDSY2234 (T588A, VSY137 and VSY139). (A) Quantification
of competitive uptake by BMDMs expressed as percent internalization ratios (PIRs; percentages of yeasts of each strain in the total number of yeasts from both
competitor strains). Cultures were prepared and visualized as described above for Fig. 4C. (B) Quantification of competitive adherence to BMDMs expressed as
percent adherence ratios (PARs). Experimental conditions were similar to those described for Fig. 5A. Results are means  SD of a minimum of three
independent experiments performed in duplicate (with fluorescent protein labeling swapping between strains). P values of0.05 were considered significant,
and asterisks represent P value ranges (*, P 0.05, Mann-Whitney U test).
FIG 7 Phagocytosis and adherence of C. glabrata to THP-1-derived macro-
phage-like cells. The test strains were matched clinical isolates DSY562 and
DSY565 and isogenic strains on the DSY562 strain background harboring
either its original CgPDR1 wild-type allele (PDR1) or the hyperactive
CgPDR1L280F allele from DSY565 (L280F). (A) Quantification of competitive
uptake by THP-1-derived phagocytes as percent internalization ratios (PIRs;
percentage of yeasts of each strain in the total number of yeasts from both
strains). Experimental conditions were those described for the phagocytosis
experiments in the legend to Fig. 4. (B) Quantification of competitive adher-
ence to THP-1-derived phagocytes as percent adherence ratios (PARs; per-
centage of yeasts of each strain in the total number of yeasts fromboth strains).
Experimental conditions were similar to those described for the adherence
experiments shown in Fig. 5. Results are means SD of a minimum of three
independent experiments performed in duplicate (with fluorescent protein
labeling swapping between strains). P values of0.05 were considered signif-
icant, and asterisks represent P value ranges (*, P  0.05, Mann-Whitney U
test).
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cells, using cell lines CHO-Lec2, HeLa, and Caco-2. Lec2 cells
present N-acetyl lactosamine (Gal1-4 GlcNAc) as the terminal
glycosylation of complexN-linked carbohydrates, which increases
binding ofC. glabrata. This type of cells was used initially to testC.
glabrata adherence and the role of specific adhesins in this process
(31). We found that most yeasts remained adherent to Lec2 cell
monolayers (up to around 60% of the inocula), as previously re-
ported (31), while adherence to human HeLa or Caco-2 cells was
lower (20 to 30% of the inocula). The CgPDR1 allele containing
the GOF caused an increased adherence to all tested epithelial cell
lines in comparison to the wild-type allele in an isogenic strain
background (Fig. 8). A similar tendency was found when testing
the clinical isolates DSY562 and DSY565 (data not shown).
Galactose reversesdifferencesoncompetitiveuptake andad-
herence to BMDMs. The fact that adherence of C. glabrata to
CHO-Lec2 epithelial cells is increased in comparison to other ep-
ithelial cells, including parentCHOcells, suggests a central role for
yeast cell wall lectins binding host cell N-acetyl lactosamine. Fol-
lowing the observation that our strains did indeed adhere strongly
to Lec2 cells, we wondered whether a similar process might medi-
ate the interaction with phagocytes. We thus tested the effect of
supplementing the culturemediumwith galactose, serving here as
a surrogate for the ligand N-acetyl lactosamine (a disaccharide of
1-4-bound N-acetylglucosamine and galactose). Repeating the
competitive coincubation of C. glabrata strains bearing different
CgPDR1 alleles with BMDMs in the presence of galactose revealed
an influence of this monosaccharide on adherence and uptake by
BMDMs. Galactose completely eliminated differences in PIR and
PAR at concentrations above 1.0 mM and 0.5 mM, respectively
(Fig. 9A and B). This resulted from the fact that phagocytic and
adhesion indexes (PI and AI, respectively, representing the num-
ber of yeasts associated to 100 BMDMs) were lowered for strain
DSY562 to match those measured for DSY565, which were not
affected by galactose (data not shown). Thus, galactose seems to
competitively inhibit adherence of the strain bearing thewild-type
CgPDR1 allele to macrophages, while not affecting adherence of
the strain bearing the hyperactive CgPDR1 allele.
DISCUSSION
The influence of the development of drug resistance in yeast
pathogens on virulence or even the interaction with cells of the
innate immune system specifically is an emerging subject (32). As
a follow-up to the elucidation by our group thatGOFmutations in
CgPDR1 mediate not only azole resistance but also gain of viru-
lence inC. glabrata (13), we investigated in this work the impact of
suchmutations on the interaction withmammalian host cells.We
employed a model based on competitive coincubation of mam-
malian cell cultures with mixed inocula of two C. glabrata strains
harboring differentCgPDR1 alleles.We used yeasts expressing the
fluorescent protein GFP or RFP to allow strain identification. A
similar system has successfully been employed by Keppler-Ross et
al. to study the recognition of yeasts by macrophages (33). The
competitive design was chosen because of its potential to uncover
slight phenotypic differences that might otherwise go undetected.
Our first approach regarding labeling of the yeasts with fluo-
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FIG 8 Adherence of C. glabrata to epithelial cells. Confluent cell monolayers
in 24-well plates of epithelial cell lines CHO-Lec2, CaCo-2, and HeLa were
inoculated with 3.0 105 log-phase yeast cells in a 1:1 mix of two competitor
strains. The test strains were isogenic strains on theDSY562 strain background
harboring theDSY562CgPDR1wild-type allele (PDR1, VSY101) or the hyper-
activeCgPDR1L280F allele fromDSY565 (L280F, VSY102). Yeasts were allowed
to adhere for 30 min, and the cultures were washed to remove nonadherent
yeast cells. Epithelial cell monolayers were disrupted, and the resulting yeast
suspensions were plated onto YPDAmedium to count CFU. Quantification of
adherent yeasts is expressed as percent adherence ratios (PARs; percentage of
yeasts of each strain in the total number of yeasts from both strains). Results
are means  SD of a minimum of three independent experiments. P values
of 0.05 were considered significant, and asterisks represent P value ranges
(*, P 0.05, unpaired Student’s t test).
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FIG 9 Phagocytosis and adherence of C. glabrata to BMDMs in medium supplemented with galactose. The test strains were the isogenic strain pair on the
DSY562 strain background harboring the DSY562 CgPDR1 wild-type allele (PDR1) or the hyperactive CgPDR1L280F allele from DSY565 (L280F). (A) Quanti-
fication of competitive uptake by BMDMs expressed as percent internalization ratios (PIRs; percentages of yeasts of each strain in the total number of yeasts from
both competitor strains). Experimental conditions were similar to those described for Fig. 4C, with the exception that they were performed in medium
supplemented with different concentrations of galactose. (B) Quantification of competitive adherence to BMDMs expressed as percent adherence ratios (PARs).
Experimental conditions were similar to those described for Fig. 5A, with the exception that they were performed in medium supplemented with different
concentrations of galactose. Results are means SD of a minimum of three independent experiments performed in duplicate (with fluorescent protein labeling
swapping between strains). P values of 0.05 were considered significant, and asterisks represent P value ranges (ns, P 	 0.05; **, P  0.01, Kruskal-Wallis
nonparametric test, followed by Dunn’s post hoc test for multiple comparisons between pairs of competitor strains).
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rescent proteins relied on the use of URA3 CgCEN-ARS plasmid
pCgACU-5 (28). Three tandemly fusedGFP sequence copies from
plasmid pBS-3xGFP-TRP1 (34) and yeast-enhanced monomeric
red fluorescent protein (yEmRFP) from plasmid yEpGAP-Cherry
(29) were cloned in the vector under the control of the S. cerevisiae
glyceraldehyde-3-phosphate dehydrogenase isozyme 3 gene
(TDH3) promoter (pCgACU-TDH3p-3xGFP). However, ex-
pressing 3 copies of GFP from this plasmid led to a significant
growth defect in ourC. glabrata strains (data not shown).We tried
a number of modifications, including expressing one copy of GFP
only, reducing theTDH3 promoter size, using the alternative GFP
gene from pYESmtGFP (35), linearizing the plasmid for integra-
tion at theCgCEN8 locus, or replacing the TDH3 promoter by the
TEF3 or the ACT1 promoters. None of these approaches yielded
satisfactory results, since constructed strains all showed either a
similar growth defect or a lack of optimal GFP expression (data
not shown). The problem was finally solved by using plasmid
pGRB2.3 (see Materials and Methods), a similar centromere se-
quence and autonomously replicating sequence (CEN-ARS) plas-
mid containing GFP expressed under the control of the S. cerevi-
siae 3-phosphoglycerate kinase gene (PGK1) promoter in plasmid
pGRB2.2 (27). Our results highlight the need for carefully engi-
neering strains to avoid in vitro fitness defects that would other-
wise bias competition assays with mammalian cells.
C. glabrata is known to be able to persist in mice following
intravenous (i.v.) infection for long periods of time without lead-
ing to a fatal infection. This is the case even in immunocompetent
animals (16, 19). In fact,C. glabrata is able to survive and replicate
inside macrophages following phagocytosis (22, 23). Recently,
Seider et al. referred to C. glabrata as a facultative intracellular
pathogen, based on their finding that it actively modifies the
phagolysosome environment and ultimately replicates and leads
to macrophage lysis (23). We observed a similar replication be-
havior in our experimental setting, with the first yeast sister buds
becoming visible after 5 h of coincubation and a 6-fold increase in
intracellular dividing yeasts after 24 h. Just as reported by Seider et
al., incubating the cocultures for longer periods eventually re-
sulted in the lysis ofmacrophages. It has previously been suggested
that overexpression of efflux pumps may allow C. neoformans to
counteract phagolysosome acidification and thus increase fungal
intracellular survival in macrophages (36). Importantly, this does
not seem to be the case in the context of our C. glabrata strains.
Even though the L280F GOF mutation leads to a 50-fold overex-
pression ofCgCDR1 and a 4-fold overexpression ofCgCDR2 (13),
we did not observe any influence on survival and replication
within macrophages. CgPDR1 did not affect the macrophage re-
sponse in terms of cytokine production either. CgPDR1 did, how-
ever, modulate adherence to and phagocytosis by primarymurine
macrophages. GOF mutations on this gene led to decreased ad-
herence and phagocytosis. This observation was not restricted to
murine macrophages and was also observed in human THP1-
derived macrophage-like cells. To rule out an influence of the
growth conditions in selective minimal growth medium, we re-
peated competitive phagocytosis tests with log-phase yeasts grown
for two generations in rich medium (YPD). There was no detect-
able loss of the episomal plasmids bearing the fluorescent pro-
teins, and the results closely reproduced those found using the
selective minimal medium (data not shown).
Since CgPdr1 target genes CgCDR1 and PUP1 are both par-
tially implicated in the CgPDR1-mediated gain of virulence in C.
glabrata (14), we also tested the influence of these genes on phago-
cytosis by and adherence to BMDMs. Interestingly, the double
knockout ofCgCDR1 and PUP1 led to an increase in phagocytosis
in competition with the parent strain but did not influence bind-
ing to macrophages. These results recall a previously suggested
distinction between adherence to macrophages and the subse-
quent actin-mediated phagocytosis (37) and ultimately suggest
that CgCDR1 and PUP1 participate in the actin-mediated phago-
cytosis step only.
Unlike what we observed in the interaction with phagocytes,
CgPDR1 hyperactivity does not seem to decrease adherence to
mammalian epithelial cells but rather seems to increase it. The
phenotypewas slightlymore evident when testing CHO-Lec2 cells
than HeLa or Caco-2 cells, possibly because of the increased ad-
herence of C. glabrata to the former cell line. However, the differ-
ence in adherence was observed in all cases. This result is a priori
consistent with the previously described gain of virulence in our
strains, since adherence to host epithelial surfaces is thought to be
a virulence mechanism in C. glabrata (38). This way, azole-resis-
tantC. glabrata cells harboringCgPDR1GOFmutations employ a
complementary strategy to achieve enhanced virulence. The de-
creased ability of innate immune cells (such as macrophages) to
captureC. glabrata, representing an immune evasionmechanism,
together with the increased adherence to epithelial cells would
allow C. glabrata to both persist in and cause damage to the host.
The combination of these opposite adherence profiles contributes
to the resulting enhanced virulence caused by CgPDR1 GOF mu-
tations. According to previously published data, C. glabrata
pathogenesis appears to rely on immune evasion strategies to per-
sist within mammalian hosts (16). Prevention of phagocytosis
may be the most basic mechanism involved in the process (20).
Yeasts prevent phagocytosis by masking immunostimulatory
PAMPs from host recognition by PRRs (20). Prominent examples
include -glucan shielding with a mannoprotein coat in C. albi-
cans, production of an -(1,3)-glucan layer that overlays the im-
munostimulatory -glucan inHistoplasma capsulatum, modifica-
tion of cell wall glucan polymer linkage from a -(1,3)-glucan to
an -(1,3)-glucan in Paracoccidioides brasiliensis, or increase in
the size of the Cryptococcus neoformans antiphagocytic polysac-
charide capsule (20). These mechanisms all have in common that
they rely on cell wall carbohydrate modifications on the fungus
side to mask it from recognition by the host’s C-type lectin recep-
tor Dectin-1. Recently, Kuhn andVyas have presented evidence of
the reverse paradigm, whereby a fungal lectin mediates adherence
to a mammalian cell carbohydrate ligand (37). The lectin is the
glycosylphosphatidylinositol (GPI)-anchored cell wall adhesin
EPA1, which is a member of an extensive family of related EPA
genes previously established as a major mediator of adhesion to
epithelial cells in vitro (25, 31) and a probable contributor to col-
onization in vivo and virulence (22, 25). The regulation of EPA1 is
complex (25, 39–41), and its expression is known to be highly
heterogeneous between different C. glabrata strains (apparently
due to differences in subtelomeric transcriptional silencing) (42).
Preliminary data collected in our lab support the hypothesis
that CgPDR1 controls the expression of cell wall adhesins in our
strains. On one hand, whole-genome transcriptional analyses
showed that GOF mutations in CgPDR1 regulate several GPI-an-
chored cell wall adhesins, including some in the EPA family (14).
We observed a difference in adherence not only to phagocytes but
to epithelial cells as well, even though the latter was less striking.
Vale-Silva et al.
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The phenotype was also affected by galactose, which is known to
be the terminal monosaccharide residue of Epa ligands (43). We
found that galactose could revertCgPDR1-mediated differences in
phagocytosis when added to the medium in concentrations in the
order of 5.0 mM; Cormack et al. describe 10 mM as the concen-
tration required to inhibit 50% of the adherence to HEp-2 epithe-
lial cells (31). In our experiments, galactose eliminated differences
between the two strains by partially inhibiting adherence of the C.
glabrata strain bearing the wild-type CgPDR1 allele while not af-
fecting the competitor drug-resistant strain. This suggests that
decreased adherence and phagocytosis by macrophages in strains
carrying hyperactive CgPDR1 alleles may be caused by the de-
creased expression of a galactose-binding lectin on the yeast cell
wall. Furthermore, preliminary data in our strains suggest that
there are no qualitative or quantitative differences in carbohydrate
composition in the cell wall (data not shown).
Cell wall adhesins mediate increases in adherence to mamma-
lian cells, as described for epithelial cells (22, 25, 31) and, more
recently, to phagocytes (37). In the case of our work, GOF muta-
tions in CgPDR1 led to decreased adherence and phagocytosis by
macrophages but in contrast seemed to favor increased adherence
to epithelial cells, thus suggesting a more complex situation re-
quiring future investigations. We plan a multisystem approach
based upon genomic, transcriptomic, and proteomic analyses of
cell wall components in our strains, as well as in other model C.
glabrata strains, in the search for candidate CgPDR1-regulated
genes mediating interaction with mammalian cells.
In conclusion, starting from the known drug resistance and
gain of virulence mediated by GOF mutations in the zinc cluster
transcription factor CgPDR1 (13), we showed in this work that C.
glabrata may employ a strategy based on CgPDR1-mediated eva-
sion from adherence and phagocytosis by murine and human
phagocytes. Furthermore, the same alterations favor adherence to
epithelial cells. This shows thatCgPDR1modulates the interaction
with mammalian cells and may contribute to the previously de-
scribed gain of virulence in different ways. The zinc cluster tran-
scription factor CgPDR1 thus stands out as another regulator of
host-pathogen interactions in C. glabrata.
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